Triple artemisinin-based combination therapies for malaria: proceed with caution – Authors' reply

Rob W. van der Pluijm; Aung Pyae Phyo; Dysoley Lek; Sir Nicholas White; Arjen M. Dondorp

doi:10.1016/s0140-6736(20)32677-5

Related publications

Letter2022

Is triple artemisinin-based combination therapy necessary for uncomplicated malaria?

Rob W. van der Pluijm, Thomas J. Peto, Mainga Hamaluba, James J. Callery, Rupam Tripura, Sir Nicholas White, Arjen M. Dondorp

The Lancet Infectious Diseases

Letter2015

Artemisinin resistance in Myanmar – Authors' reply

Mallika Imwong, Kyaw Myo Tun, Tin Maung Hlaing, Eric P.M. Grist, Philippe J. Guérin, Frank Smithuis, Arjen M. Dondorp, Nicholas Day, François Nosten, Sir Nicholas White, Charles J. Woodrow

The Lancet Infectious Diseases

Letter2020

Primaquine for Plasmodium vivax malaria treatment – Authors' reply

Ric N. Price, Walter Taylor, Kamala Thriemer, Sir Nicholas White, Nicholas Day

The Lancet

Article2015

Optimal population-level deployment of artemisinin combination therapies

Tran Dang Nguyen, Piero Olliaro, Arjen M. Dondorp, J. Kevin Baird, Ha Minh Lam, Jeremy Farrar, Guy Thwaites, Sir Nicholas White, Maciej F. Boni

Tropical Medicine & International Health

Article2011

Artesunate for severe malaria in African children – Authors' reply

Arjen M. Dondorp, Caterina Fanello, Lorenz von Seidlein, Nicholas Day, Sir Nicholas White